Literature DB >> 28459139

Exploring the limits of the usefulness of mutagenesis in studies of allosteric mechanisms.

Qingling Tang1, Aileen Y Alontaga1, Todd Holyoak2, Aron W Fenton1.   

Abstract

The outcome of structure-guided mutational analyses is often used in support of postulated mechanisms of protein allostery. However, the limits of how informative mutations can be in understanding allosteric mechanisms are not completely clear. Here, we report an exercise to evaluate whether mutational data can support a simplistic mechanistic model, developed with minimal data inputs. Due to the lack of a mechanism to explain how alanine allosterically modifies the affinity of human liver pyruvate kinase (approved symbol PKLR) for its substrate, phosphoenolpyruvate, we proposed a speculative allosteric mechanism for this system. Within the allosteric amino-acid-binding site (something in the effector site must, of necessity, contribute to the allosteric mechanism), we implemented multiple mutational strategies: (1) site-directed random mutagenesis at positions that contact bound alanine and (2) mutations to probe specific questions. Despite acknowledged inadequacies used to formulate the speculative mechanism, many mutations modified the allosteric coupling constant (Qax ) consistent with that mechanism. The observed support for this speculative mechanism leaves us to ponder the best use of mutational data in structure-function studies of allosteric mechanisms. The mutational databank derived from this exercise has an independent value for training and testing algorithms specific to allostery.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  allosteric mechanism; allosteric regulation; allostery; liver pyruvate kinase

Mesh:

Substances:

Year:  2017        PMID: 28459139      PMCID: PMC5561510          DOI: 10.1002/humu.23239

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  44 in total

1.  The pyruvate kinase model system, a cautionary tale for the use of osmolyte perturbations to support conformational equilibria in allostery.

Authors:  Aron W Fenton; Troy A Johnson; Todd Holyoak
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

2.  Effects of primary sequence differences on the global structure and function of an enzyme: a study of pyruvate kinase isozymes.

Authors:  T G Consler; S H Woodard; J C Lee
Journal:  Biochemistry       Date:  1989-10-31       Impact factor: 3.162

3.  Domain interaction in rabbit muscle pyruvate kinase. II. Small angle neutron scattering and computer simulation.

Authors:  T G Consler; E C Uberbacher; G J Bunick; M N Liebman; J C Lee
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Allosteric regulation of human liver pyruvate kinase by peptides that mimic the phosphorylated/dephosphorylated N-terminus.

Authors:  Charulata B Prasannan; Qingling Tang; Aron W Fenton
Journal:  Methods Mol Biol       Date:  2012

5.  Monitoring allostery in D2O: a necessary control in studies using hydrogen/deuterium exchange to characterize allosteric regulation.

Authors:  Charulata B Prasannan; Antonio Artigues; Aron W Fenton
Journal:  Anal Bioanal Chem       Date:  2011-06-24       Impact factor: 4.142

6.  Domain interaction in rabbit muscle pyruvate kinase. I. Effects of ligands on protein denaturation induced by guanidine hydrochloride.

Authors:  T G Consler; J C Lee
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

7.  Energetic coupling between an oxidizable cysteine and the phosphorylatable N-terminus of human liver pyruvate kinase.

Authors:  Todd Holyoak; Bing Zhang; Junpeng Deng; Qingling Tang; Charulata B Prasannan; Aron W Fenton
Journal:  Biochemistry       Date:  2013-01-11       Impact factor: 3.162

8.  Allostery in rabbit pyruvate kinase: development of a strategy to elucidate the mechanism.

Authors:  R H Friesen; R J Castellani; J C Lee; W Braun
Journal:  Biochemistry       Date:  1998-11-03       Impact factor: 3.162

9.  The negative dominant effects of T340M mutation on mammalian pyruvate kinase.

Authors:  R H Friesen; J C Lee
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

10.  An activating interaction between the unphosphorylated n-terminus of human liver pyruvate kinase and the main body of the protein is interrupted by phosphorylation.

Authors:  Aron W Fenton; Qingling Tang
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

View more
  7 in total

1.  RheoScale: A tool to aggregate and quantify experimentally determined substitution outcomes for multiple variants at individual protein positions.

Authors:  Abby M Hodges; Aron W Fenton; Larissa L Dougherty; Andrew C Overholt; Liskin Swint-Kruse
Journal:  Hum Mutat       Date:  2018-08-28       Impact factor: 4.878

2.  Reports from CAGI: The Critical Assessment of Genome Interpretation.

Authors:  Roger A Hoskins; Susanna Repo; Daniel Barsky; Gaia Andreoletti; John Moult; Steven E Brenner
Journal:  Hum Mutat       Date:  2017-09       Impact factor: 4.878

3.  AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations.

Authors:  Zhen Wah Tan; Enrico Guarnera; Wei-Ven Tee; Igor N Berezovsky
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

4.  Identification of biochemically neutral positions in liver pyruvate kinase.

Authors:  Tyler A Martin; Tiffany Wu; Qingling Tang; Larissa L Dougherty; Daniel J Parente; Liskin Swint-Kruse; Aron W Fenton
Journal:  Proteins       Date:  2020-06-27

5.  Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response.

Authors:  Wei-Ven Tee; Enrico Guarnera; Igor N Berezovsky
Journal:  PLoS Comput Biol       Date:  2018-06-18       Impact factor: 4.475

6.  Mutational mimics of allosteric effectors: a genome editing design to validate allosteric drug targets.

Authors:  Qingling Tang; Maria T Villar; Antonio Artigues; John P Thyfault; Udayan Apte; Hao Zhu; Kenneth R Peterson; Aron W Fenton
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

7.  Rheostat positions: A new classification of protein positions relevant to pharmacogenomics.

Authors:  Aron W Fenton; Braelyn M Page; Arianna Spellman-Kruse; Bruno Hagenbuch; Liskin Swint-Kruse
Journal:  Med Chem Res       Date:  2020-06-07       Impact factor: 1.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.